AR022890A1 - Citoquinas mamiferas; reactivos relacionados y metodos - Google Patents

Citoquinas mamiferas; reactivos relacionados y metodos

Info

Publication number
AR022890A1
AR022890A1 ARP000101059A ARP000101059A AR022890A1 AR 022890 A1 AR022890 A1 AR 022890A1 AR P000101059 A ARP000101059 A AR P000101059A AR P000101059 A ARP000101059 A AR P000101059A AR 022890 A1 AR022890 A1 AR 022890A1
Authority
AR
Argentina
Prior art keywords
methods
cytokins
mammary
related reagents
reagents
Prior art date
Application number
ARP000101059A
Other languages
English (en)
Original Assignee
Schering Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering Corp filed Critical Schering Corp
Publication of AR022890A1 publication Critical patent/AR022890A1/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • C07K14/54—Interleukins [IL]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2799/00—Uses of viruses
    • C12N2799/02—Uses of viruses as vector
    • C12N2799/021—Uses of viruses as vector for the expression of a heterologous nucleic acid

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Biochemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Immunology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Investigating Or Analysing Biological Materials (AREA)

Abstract

Se proporcionan genes purificados que codifican citoquina de un mamífero, reactivos relacionados con los mismos, incluyendo proteínas purificadas,anticuerpos específicos y ácidos nucleicos que codifican a esta molécula. Además se proporcionanmétodos de uso de dichos reactivos y equipos de diagnostico.
ARP000101059A 1999-03-11 2000-03-09 Citoquinas mamiferas; reactivos relacionados y metodos AR022890A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US26790199A 1999-03-11 1999-03-11

Publications (1)

Publication Number Publication Date
AR022890A1 true AR022890A1 (es) 2002-09-04

Family

ID=23020618

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP000101059A AR022890A1 (es) 1999-03-11 2000-03-09 Citoquinas mamiferas; reactivos relacionados y metodos

Country Status (9)

Country Link
EP (2) EP1942114A3 (es)
JP (1) JP2003500010A (es)
AR (1) AR022890A1 (es)
AT (1) ATE420894T1 (es)
AU (1) AU3873200A (es)
CA (1) CA2366706A1 (es)
DE (1) DE60041393D1 (es)
ES (1) ES2319958T3 (es)
WO (1) WO2000053631A1 (es)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2804435A1 (fr) * 2000-01-27 2001-08-03 Pf Medicament COMPLEXE ISOLE COMPRENANT UNE PROTEINE NNT-1 ET EN OUTRE AU MOINS UNE PROTEINE CLF-1 ET/OU UNE PROTEINE sCNTFRalpha
US7045283B2 (en) * 2000-10-18 2006-05-16 The Regents Of The University Of California Methods of high-throughput screening for internalizing antibodies
CA2525184C (en) 2003-05-09 2012-10-30 Centocor, Inc. Il-23p40 specific immunoglobulin derived proteins, compositions, methods and uses
AR051444A1 (es) 2004-09-24 2007-01-17 Centocor Inc Proteinas derivadas de inmunoglobulina especifica de il-23p40, composiciones, epitopos, metodos y usos
HUE042561T2 (hu) 2005-06-30 2019-07-29 Janssen Biotech Inc Anti-IL-23-ellenanyagok, készítmények, eljárások és alkalmazások
SG165322A1 (en) 2005-08-31 2010-10-28 Schering Corp Engineered anti-il-23 antibodies
ES2517420T3 (es) 2005-12-29 2014-11-03 Janssen Biotech, Inc. Anticuerpos anti-IL-23 humanos, composiciones, procedimientos y usos
CN101663320A (zh) 2007-02-23 2010-03-03 先灵公司 工程改造的抗IL-23p19抗体
KR101520110B1 (ko) 2007-02-23 2015-05-18 머크 샤프 앤드 돔 코포레이션 가공된 항-ＩＬ-23ｐ19 항체
EP2417974A1 (en) 2007-02-28 2012-02-15 Schering Corporation Combination therapy for treatment of immune disorders
CA2679381A1 (en) 2007-02-28 2008-09-04 Schering Corporation Engineered anti-il-23r antibodies
US9803010B2 (en) 2012-06-27 2017-10-31 Merck Sharp & Dohme Corp. Crystalline anti-human IL-23p19 antibodies
UA117466C2 (uk) 2012-12-13 2018-08-10 Мерк Шарп Енд Доме Корп. СТАБІЛЬНИЙ СКЛАД У ВИГЛЯДІ РОЗЧИНУ АНТИТІЛА ДО IL-23p19
CN110913906A (zh) 2017-05-02 2020-03-24 默沙东公司 抗lag3抗体的制剂和抗lag3抗体与抗pd-1抗体的共制剂
JOP20190260A1 (ar) 2017-05-02 2019-10-31 Merck Sharp & Dohme صيغ ثابتة لأجسام مضادة لمستقبل الموت المبرمج 1 (pd-1) وطرق استخدامها
KR20210093973A (ko) 2018-11-20 2021-07-28 얀센 바이오테크 인코포레이티드 항-il23 특이적 항체로 건선을 치료하는 안전하고 효과적인 방법
MX2021014302A (es) 2019-05-23 2022-01-04 Janssen Biotech Inc Metodo para tratar la enfermedad inflamatoria del intestino con una terapia de combinacion de anticuerpos contra il-23 y tnf alfa.

Family Cites Families (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3940475A (en) 1970-06-11 1976-02-24 Biological Developments, Inc. Radioimmune method of assaying quantitatively for a hapten
NL154598B (nl) 1970-11-10 1977-09-15 Organon Nv Werkwijze voor het aantonen en bepalen van laagmoleculire verbindingen en van eiwitten die deze verbindingen specifiek kunnen binden, alsmede testverpakking.
US3817837A (en) 1971-05-14 1974-06-18 Syva Corp Enzyme amplification assay
US3939350A (en) 1974-04-29 1976-02-17 Board Of Trustees Of The Leland Stanford Junior University Fluorescent immunoassay employing total reflection for activation
US3996345A (en) 1974-08-12 1976-12-07 Syva Company Fluorescence quenching with immunological pairs in immunoassays
US4275149A (en) 1978-11-24 1981-06-23 Syva Company Macromolecular environment control in specific receptor assays
US4277437A (en) 1978-04-05 1981-07-07 Syva Company Kit for carrying out chemically induced fluorescence immunoassay
US4366241A (en) 1980-08-07 1982-12-28 Syva Company Concentrating zone method in heterogeneous immunoassays
ATE64618T1 (de) 1982-03-15 1991-07-15 Schering Corp Hybride dns, damit hergestellte bindungszusammensetzung und verfahren dafuer.
US4659678A (en) 1982-09-29 1987-04-21 Serono Diagnostics Limited Immunoassay of antigens
NZ207394A (en) 1983-03-08 1987-03-06 Commw Serum Lab Commission Detecting or determining sequence of amino acids
US4816567A (en) 1983-04-08 1989-03-28 Genentech, Inc. Recombinant immunoglobin preparations
US4859609A (en) 1986-04-30 1989-08-22 Genentech, Inc. Novel receptors for efficient determination of ligands and their antagonists or agonists
US5470952A (en) * 1993-10-20 1995-11-28 Regeneron Pharmaceuticals, Inc. CNTF and IL-6 antagonists
EP1950226A3 (en) * 1995-08-01 2010-08-11 F. Hoffmann-La Roche AG An antibody against a receptor for human interleukin - 12 and its use
AUPO224696A0 (en) * 1996-09-11 1996-10-03 Amrad Operations Pty. Limited A novel haemopoietin receptor and genetic sequences encoding same
AU5733898A (en) * 1997-01-16 1998-08-07 Genetics Institute Inc. Member of the hematopoietin receptor superfamily
US5741772A (en) * 1997-02-03 1998-04-21 Amgen Inc. Neurotrophic factor NNT-1
HU225307B1 (en) * 1997-02-03 2006-09-28 Amgen Inc The neurotrophic factor nnt-1
AU7276098A (en) * 1997-05-01 1998-11-24 Zymogenetics Inc. Mammalian cytokine-like receptor
AU8165298A (en) * 1997-06-30 1999-01-19 Human Genome Sciences, Inc. Cardiotrophin-like cytokine
GB9721961D0 (en) * 1997-10-16 1997-12-17 Glaxo Group Ltd Novel molecules
CA2311640A1 (en) * 1997-12-03 1999-06-10 Genentech, Inc. Polypeptides and nucleic acids encoding the same
WO1999035264A1 (en) * 1998-01-09 1999-07-15 Immunex Corporation H14 dna and polypeptides
AU2661199A (en) * 1998-02-06 1999-08-23 Schering Corporation Mammalian receptor proteins; related reagents and methods
EP1181366B2 (en) * 1999-06-01 2013-08-21 Merck Sharp & Dohme Corp. Mammalian receptor proteins; related reagents and methods
FR2804435A1 (fr) * 2000-01-27 2001-08-03 Pf Medicament COMPLEXE ISOLE COMPRENANT UNE PROTEINE NNT-1 ET EN OUTRE AU MOINS UNE PROTEINE CLF-1 ET/OU UNE PROTEINE sCNTFRalpha

Also Published As

Publication number Publication date
CA2366706A1 (en) 2000-09-14
EP1159299B1 (en) 2009-01-14
EP1159299A1 (en) 2001-12-05
ATE420894T1 (de) 2009-01-15
EP1942114A3 (en) 2008-08-27
ES2319958T3 (es) 2009-05-18
AU3873200A (en) 2000-09-28
EP1942114A2 (en) 2008-07-09
JP2003500010A (ja) 2003-01-07
DE60041393D1 (de) 2009-03-05
WO2000053631A1 (en) 2000-09-14

Similar Documents

Publication Publication Date Title
AR022890A1 (es) Citoquinas mamiferas; reactivos relacionados y metodos
MY157028A (en) Mammalian cytokine, related reagents
AR022236A1 (es) Citoquinas mamiferas purificadas; reactivos y metodos relacionados
HUP0301102A2 (hu) Emlős citokinok; kapcsolódó reagensek és eljárások
ATE500323T1 (de) Subtilisin-variante
DK0920505T3 (da) Pattedyrcelleoverfladeantigener og tilhörende reagenser
AR014891A1 (es) Genes aislados de proteinas de membranas de mamiferos; reactivos relacionados
AR022237A1 (es) Citoquinas mamiferas purificadas; reactivos y metodos relacionados
BR9714401A (pt) Antìgenos de supefìcie de célula de mamìfero; regentes relacionados
EP1897949A3 (en) Human interleukin-B50. Therapeutic uses
WO1998001557A3 (en) Mammalian chemokine reagents
AU8661498A (en) Mammalian cell membrane proteins; related reagents
WO1998011226A3 (en) Mammalian chemokines, related reagents
AU5587298A (en) Isolated mammalian monocyte cell genes; related reagents
ATE389018T1 (de) Cx3c chemokin-gene von säugetieren
BR9713450A (pt) Quimiocinas de mamìfero
BR9713668A (pt) Agonistas de receptores hematopoiéticos quiméricos multifuncionais
WO1998032858A3 (en) Mammalian chemokines; receptors; reagents; uses
BR9713632A (pt) Citocina de mamìfero relacionada com a il-10
ATE294237T1 (de) S?ugetier thymokingene
WO1998031810A3 (en) Mammalian chemokines; receptors; reagents; uses
WO2002068596A3 (en) Mammalian cytokines; related reagents
DK0939769T3 (da) Vertebrat-Smoothened-proteiner
WO1999047673A3 (en) Isolated mammalian membrane protein genes and related reagents
AR016145A1 (es) Citoquinas de mamifero; reactivos relacionados

Legal Events

Date Code Title Description
FB Suspension of granting procedure